Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation
Reference12 articles.
1. Local consolidative non-small cell lung cancer: Long-term results of a multi-institutional, phase II, randomised study;Gomez;J Clin Oncol,2019
2. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial;Palma;Lancet,2019
3. Consolidative radiotherapy for limited metastatic non-small cell lung cancer: A phase 2 randomised clinical trial;Iyengar;JAMA Oncol,2018
4. Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: A prospective, randomised multicentre phase II trial;Ost;J Clin Oncol,2018
5. Primary outcomes of a phased II randomised trial of observation versus stereotactic ablative radiation for oligometastatic prostate cancer (ORIOLE);Phillips;Int J Radiat Oncol Biol Phys,2019
Cited by 99 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Exploring Radiotherapy as a Promising Alternative for Managing Advanced Upper Tract Urothelial Carcinoma: Rescuing Chemotherapy-Intolerant Patients;Clinical Genitourinary Cancer;2024-12
2. Brachial plexopathy following stereotactic body radiation therapy in apical lung malignancies: A dosimetric pooled analysis of individual patient data;Radiotherapy and Oncology;2024-11
3. Safety and Efficacy of Stereotactic Body Radiation Therapy for Ultra-central Thoracic Tumors: A Single Center Retrospective Review;International Journal of Radiation Oncology*Biology*Physics;2024-10
4. Biology-guided radiotherapy in metastatic prostate cancer: time to push the envelope?;Frontiers in Oncology;2024-09-09
5. Challenges and Opportunities in Developing an Oncology Clinical Trial Network in the United States Veterans Affairs Health Care System: The VA STARPORT Experience;Current Oncology;2024-08-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3